openPR Logo
Press release

Procalcitonin Antibody Market Outlook, and Opportunity Analysis, 2018 - 2026

08-20-2018 02:57 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Procalcitonin Antibody Market Outlook, and Opportunity

Procalcitonin (PCT) is a peptide precursor of the hormone calcitonin, and belongs to calcitonin (CT) superfamily of peptides. Procalcitonin is a 116 amino acid peptide that has an estimated molecular weight of 14.5 kDa. It can be segregated into three parts, namely immature calcitonin, calcitonin carboxyl-terminus peptide-1, and amino terminus of the PCT region. Procalcitonin was first classified by Bernard Roos and Leonard J. Deftos in the early 1970s. Procalcitonin is produced by C cells of the thyroid and by endocrine cells of the lung. In human body, level of unprocessed procalcitonin rises extensively after shock, injury or bacterial infection, which increases the production of procalcitonin in the body. This might lead to organ dysfunction and call for immediate treatment of the patient. The level of procalcitonin in the body can be diagnosed with wet lab analysis using procalcitonin antibody. On the basis of antibody type, the procalcitonin antibody market is segmented into polyclonal procalcitonin antibody and monoclonal procalcitonin antibody.

Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/1907

Procalcitonin Antibody Market Dynamics

Procalcitonin variance in healthy individuals and microbial infected individuals has led to the use of PCT as a marker to develop antibiotic therapy and improve identification of bacterial infections. Increasing prevalence of various chronic diseases such as hepatitis, sepsis, tuberculosis, and HIV is expected to propel growth of the procalcitonin antibody market. For instance, according to the World Health Organization (WHO) fact sheet of 2018, cancer was responsible for 8.8 million deaths in 2015 globally. Moreover, according to the World Health Organization report of 2017, around 1.0 million deaths occurred due to HIV related illnesses worldwide. Furthermore, WHO 2017, fact sheet revealed that 71 million people were having chronic hepatitis C infection. Approximately 399,000 people die each year from hepatitis C, mostly from cirrhosis and hepatocellular carcinoma. These incidences have led to the adoption of new techniques and procedures by research institutes and hospitals for quick diagnosis of the diseases, so that it can be treated within the earliest time frame. Moreover, increasing funding for research and development by commercial market players and government agencies for the development of efficient, safer, and innovative products for the treatment of diseases such as cancer is fueling growth of the procalcitonin antibody market. For instance, in 2018, the U.S government approved US$ 3 billion funds for the National Institutes of Health research and development activities.

Procalcitonin Antibody Market – Regional Insights

On the basis of region, the global procalcitonin antibody market is segmented into North America, Europe, Latin America, Asia Pacific, Middle East, and Africa. North America is estimated to account for the largest share in the global procalcitonin antibody market, owing to increasing adoption of new techniques in research, and huge national healthcare spending. For instance, according to the U.S Centers for Medicare & Medicaid Services, national healthcare spending is projected to grow at an average rate of 5.5% per year from 2017 to 2026 and will reach around US$ 5.7 trillion by 2026.

Asia Pacific is expected to exhibit significant growth in the procalcitonin antibody market, followed by Europe, owing to increasing healthcare researches and rising geriatric population vulnerable to sepsis disease. According to the Center for Strategic and International Studies, in 2015, 9.5% of the population in China was 65 years or older and as per the United Nations, it is projected to reach to 27.5% by 2050.

Access Table of Content (TOC) Of the Report @ https://www.coherentmarketinsights.com/ongoing-insight/toc/1907

Procalcitonin Antibody Market – Competitive Landscape

Key market players operating in the global procalcitonin antibody market include bioMerieux, HyTest, Roche Diagnostics, Snibe, Thermo Fisher Scientific, Vazyme Biotech, Hotgen Biotech, Getein Biotech, and Hangzhou Realy Tech Co., Ltd. Market players are involved in developing technologies, new product launches, mergers, and collaborations with major companies, in order to retain dominance in the global market. For instance, in 2017, the U.S. Food and Drug Administration (FDA) approved bioMérieux’s VIDAS B.R.A.H.M.S PCT assay test, an automated assay for measuring procalcitonin levels. This test will help physicians to make major conclusions regarding the optimal use of antibiotics in two common clinical situations, which include sepsis and lower respiratory tract infections.

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Procalcitonin Antibody Market Outlook, and Opportunity Analysis, 2018 - 2026 here

News-ID: 1189018 • Views:

More Releases from Coherent Market Insights

Saliva Collection Devices Market Growth Trajectory: Navigating Size, Share, and Future Trends (2024-2031) | Quest Diagnostics, Neogen Corporation, AboGen
Saliva Collection Devices Market Growth Trajectory: Navigating Size, Share, and …
Saliva Collection Devices Market Research focuses on the key trends prevailing in the Global Saliva Collection Devices Industry sector. The existing Industry scenario has been studied and future projections with respect to the sector have also been investigated. Market study report comprises evaluation of numerous influential factors including industry overview in terms of historic and present situation, key manufacturers, product/service application and types, key regions and marketplaces, forecast estimation
Endocrine Testing Product Market Trends and Competitive Landscape Forecast 2024 - 2031 | F. Hoffmann-la Roche Ag, Abbott Laboratories, Agilent Technologies
Endocrine Testing Product Market Trends and Competitive Landscape Forecast 2024 …
Endocrine Testing Product Market Research focuses on the key trends prevailing in the Global Endocrine Testing Product Industry sector. The existing Industry scenario has been studied and future projections with respect to the sector have also been investigated. Market study report comprises evaluation of numerous influential factors including industry overview in terms of historic and present situation, key manufacturers, product/service application and types, key regions and marketplaces, forecast estimation
Mammography Biopsy Chair Market Research Report Analysis, Future Innovations, Growth by 2024-2031 | Wolverson X-Ray Limited, Univest-X, AKRUS GmbH & Co. KG, Z&Z Medical
Mammography Biopsy Chair Market Research Report Analysis, Future Innovations, Gr …
Mammography Biopsy Chair Market Research focuses on the key trends prevailing in the Global Mammography Biopsy Chair Industry sector. The existing Industry scenario has been studied and future projections with respect to the sector have also been investigated. Market study report comprises evaluation of numerous influential factors including industry overview in terms of historic and present situation, key manufacturers, product/service application and types, key regions and marketplaces, forecast estimation
Pigmentation Disorders Treatment Market Size, Scope, Booming Growth, Analysis, Insight, Forecast, Scenario by 2030 | Abbvie Inc. (Allergan Inc.), Episciences Inc., L'ORÉAL SA (SkinCeuticals International)
Pigmentation Disorders Treatment Market Size, Scope, Booming Growth, Analysis, I …
Pigmentation Disorders Treatment Market Research focuses on the key trends prevailing in the Global Pigmentation Disorders Treatment Industry sector. The existing Industry scenario has been studied and future projections with respect to the sector have also been investigated. Market study report comprises evaluation of numerous influential factors including industry overview in terms of historic and present situation, key manufacturers, product/service application and types, key regions and marketplaces, forecast estimation

All 5 Releases


More Releases for Procalcitonin

Procalcitonin (CAS 56645-65-9) Market 2021 | Detailed Report
The Procalcitonin (CAS 56645-65-9) research report combines vital data incorporating the competitive landscape, global, regional, and country-specific market size, market growth analysis, market share, recent developments, and market growth in segmentation. Furthermore, the Procalcitonin (CAS 56645-65-9) research report offers information and thoughtful facts like share, revenue, historical data, and global market share. It also highlights vital aspects like opportunities, driving, product scope, market overview, and driving force. Get Free Sample PDF
Industry Outlook of Procalcitonin Market 2021 | Procalcitonin Tests Will Benefit …
Straits Research Latest 2021 Report: The Global Procalcitonin Market Research Report represents a comprehensive study on the Procalcitonin industry including current trends and status. The report can help to understand the market in-depth and strategize for business expansion accordingly in the future. In the strategic analysis process, it gives insights from marketing channel and market positioning to potential growth strategies, providing in-depth analysis for new entrants or exists competitors in the
BRAHMS Procalcitonin Market Size, Share, Development by 2024
Global Info Research offers a latest published report on BRAHMS Procalcitonin Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global BRAHMS Procalcitonin players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the BRAHMS Procalcitonin with respect to individual growth
Procalcitonin Antibody Market Size, Share, Development by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Procalcitonin Antibody market. Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue,
Procalcitonin Antibody Market Report 2018: Segmentation by Type (Polyclonal Proc …
Global Procalcitonin Antibody market research report provides company profile for Ningbo Medicalsystem Biotechnology, Snibe, Vazyme Biotech, Getein Biotech, Hotgen Biotech, Lumigenex, Shanghai Medicine'nest Pharmaceutical, Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, Wondfo and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for
Procalcitonin Antibody Market Opportunity Analysis, 2018 - 2026
Procalcitonin (PCT) is a peptide precursor of the hormone calcitonin, and belongs to calcitonin (CT) superfamily of peptides. Procalcitonin is a 116 amino acid peptide that has an estimated molecular weight of 14.5 kDa. It can be segregated into three parts, namely immature calcitonin, calcitonin carboxyl-terminus peptide-1, and amino terminus of the PCT region. Procalcitonin was first classified by Bernard Roos and Leonard J. Deftos in the early 1970s. Procalcitonin